Back to NRSNW

UBS Group AG → NRSNW

UBS Group AG NRSNW Position History

NeuroSense Therapeutics Ltd. • Healthcare

Quarters held
15
Latest value
$4K
Q3 2026
Peak value
$69K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$397
Q3 2025$17K
Q3 2025$1K
Q4 2025$291
Q4 2025$13K
Q4 2025$11K
Q1 2026$64
Q1 2026$9K
Q1 2026$28K
Q2 2026$73
Q2 2026$69K
Q2 2026$6K
Q2 2026$3K
Q3 2026$52
Q3 2026$4K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$4K985——
Q3 2026$521.2K——
Q2 2026$3K4.8K——
Q2 2026$6K7.8K——
Q2 2026$69K96.0K——
Q2 2026$731.2K——
Q1 2026$28K37.1K——
Q1 2026$9K12.0K——
Q1 2026$641.2K——
Q4 2025$11K13.8K——
Q4 2025$13K17.1K——
Q4 2025$2911.2K——
Q3 2025$1K888——
Q3 2025$17K13.8K——
Q3 2025$3971.3K——

Other funds holding NRSNW

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B